Survival on dialysis among American Indians and Alaska natives with diabetes in the United States, 1995 - 2010

American Journal of Public Health

Volumn 104, Issue SUPPL. 3, 2014, Pages

  Burrows, Nilka Ríos ^a,c   Cho, Pyone ^a   Bullard, Kai McKeever ^a   Narva, Andrew S ^b   Eggers, Paul W ^b  

^a NATIONAL CENTER FOR CHRONIC DISEASE PREVENTION AND HEALTH PROMOTION   (United States)

^b NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

^c Mailstop F73 ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMERICAN INDIAN; ARTICLE; CAUCASIAN; CHRONIC KIDNEY FAILURE; DIABETIC NEPHROPATHY; ETHNOLOGY; FEMALE; HEALTH SURVEY; HUMAN; INUIT; MALE; MIDDLE AGED; MORTALITY; RENAL REPLACEMENT THERAPY; STATISTICS; SURVIVAL; UNITED STATES;

ALASKA; DIABETIC NEPHROPATHIES; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; HUMANS; INDIANS, NORTH AMERICAN; INUITS; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; POPULATION SURVEILLANCE; RENAL DIALYSIS; SURVIVAL ANALYSIS; UNITED STATES;

EID: 84900993026     PISSN: 00900036     EISSN: 15410048     Source Type: Journal    
DOI: 10.2105/AJPH.2014.301942     Document Type: Review

References (31)

1. Us renal data system. usrds 2013 annual data Report: Atlas of Chronic Kidney Disease and End-Stage Renal Disease in the United States. Bethesda, MD: National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases; 2013.
2. US Renal Data System. Renal Data Extraction and Referencing (RenDER) System [online query system]. Available at: http://www.usrds.org. Accessed May 3, 2013.
3. Burrows NR, Li Y, Williams DE. Racial and ethnic differences in trends of end-stage renal disease: United States, 1995 to 2005. Adv Chronic Kidney Dis. 2008; 15(2):147-152.
4. Centers for Disease Control and Prevention. National Diabetes Fact Sheet: National Estimates and General Information on Diabetes and Prediabetes in the United States, 2011. Atlanta, GA: US Department of Health and Human Services, Centers for Disease Control and Prevention; 2011.
5. Centers for Disease Control and Prevention. Diabetes Data and Trends. Available at: http://www.cdc.gov/ diabetes/statistics/index.htm. Accessed May 3, 2013.
6. Nelson RG, Hanson RL, Pettitt DJ, Knowler WC, Bennett PH. Survival during renal replacement therapy for diabetic end-stage renal disease in Pima Indians. Diabetes Care. 1996;19(12):1333-1337.
7. Indian Health Service. Trends in Indian Health. Available at: http://www.ihs.gov/DPS/index.cfm? module=hqPubTrends03. Accessed May 3, 2013.
8. Kidney Disease: Improving Global Outcomes (KDIGO) Anemia Work Group. KDIGO clinical practice guideline for anemia in chronic kidney disease. Kidney Int. 2012;2(4 suppl 2):279-335.
9. Sarnak MJ, Tighiouart H, Manjunath G, et al. Anemia as a risk factor for cardiovascular disease in the Atherosclerosis Risk in Communities (ARIC) study. J Am Coll Cardiol. 2002;40(1):27-33.
10. Cowie CC, Port FK, Rust KF, Harris MI. Differences in survival between black and white patients with diabetic end-stage renal disease. Diabetes Care. 1994; 17(7):681-687.
11. Murthy BV, Molony DA, Stack AG. Survival advantage of Hispanic patients initiating dialysis in the United States is modified by race. J Am Soc Nephrol. 2005; 16(3):782-790.
12. International Classification of Diseases, Ninth Revision. Geneva, Switzerland: World Health Organization; 1980.
13. Vlagopoulos PT, Tighiouart H, Weiner DE, et al. Anemia as a risk factor for cardiovascular disease and all-cause mortality in diabetes: the impact of chronic kidney disease. J Am Soc Nephrol. 2005;16(11):3403-3410.
14. Frankenfield DL, Rocco M, Roman S, McClellan W. Survival advantage for adult Hispanic hemodialysis patients? Findings from the End-Stage Renal Disease Clinical Performance Measures Project. J Am Soc Nephrol. 2003;14:180-186.
15. Yan G, Norris KC, Yu AJ, et al. The relationship of age, race, and ethnicity with survival in dialysis patients. Clin J Am Soc Nephrol. 2013;8(6):953-961.
16. Pugh JA, Tuley MR, Basu S. Survival among Mexican-Americans, non-Hispanic whites, and African-Americans with end-stage renal disease: the emergence of a minority pattern of increased incidence and prolonged survival. Am J Kidney Dis. 1994;23(6):803-807.
17. Collins AJ, Li S, Gilbertson DT, Liu J, Chen S-C, Herzog CA. Chronic kidney disease and cardiovascular disease in the Medicare population. Kidney Int Suppl. 2003;64:S24-S31.
18. Yan G, Cheung AK, Ma JZ, et al. The associations between race and geographic area and quality-of-care indicators in patients approaching ESRD. Clin J Am Soc Nephrol. 2013;8(4):610-618.
19. Buckalew VM Jr, Freedman BI. Reappraisal of the impact of race on survival in patients on dialysis. Am J Kidney Dis. 2010;55(6):1102-1110.
20. Feroze U, Noori N, Kovesdy CP, et al. Quality-of-life and mortality in hemodialysis patients: roles of race and nutritional status. Clin J Am Soc Nephrol. 2011; 6(5):1100-1111.
21. Noori N, Kovesdy CP, Dukkipati R, et al. Racial and ethnic differences in mortality of hemodialysis patients: role of dietary and nutritional status and inflammation. Am J Nephrol. 2011;33(2):157-167.
22. Kimmel PL, Fwu CW, Eggers PW. Segregation, income disparities, and survival in hemodialysis patients. J Am Soc Nephrol. 2013;24(2):293-301.
23. Sandhu GS, Khattak M, Rout P, et al. Social adaptability index: application and outcomes in a dialysis population. Nephrol Dial Transplant. 2011;26(8):2667-2674.
24. Newman JM, Marfin AA, Eggers PW, Helgerson SD. End state renal disease among Native Americans, 1983-86. Am J Public Health. 1990;80(3):318-319.
25. Sugarman JR, Lawson L. The effect of racial misclassification on estimates of end-stage renal disease among American Indians and Alaska Natives in the Pacific Northwest, 1988 through 1990. Am J Kidney Dis. 1993; 21(4):383-386.
26. Burrows NR, Li Y, Geiss LS. Incidence of treatment for end-stage renal disease among individuals with diabetes in the US continues to decline. Diabetes Care. 2010;33(1):73-77.
27. The Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med. 1993;329:977-986.
28. Stratton IM, Adler AI, Neil HA, et al. Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study. BMJ. 2000;321 (7258):405-412.
29. Adler AI, Stratton IM, Neil HA, et al. Association of systolic blood pressure with macrovascular and microvascular complications of type 2 diabetes (UKPDS 36): prospective observational study. BMJ. 2000;321 (7258):412-419.
30. UK Prospective Diabetes Study Group. Efficacy of atenolol and captopril in reducing risk of macrovascular and microvascular complications in type 2 diabetes (UKPDS 39). BMJ. 1998;317 (7160):713-720.
31. Nelson RG. Is treatment of nephropathy in type 1 diabetes efficacious but ineffective? J Am Soc Nephrol. 2011;22(3):402-404.